These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 23905644)
21. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Métrich M; Lucas A; Gastineau M; Samuel JL; Heymes C; Morel E; Lezoualc'h F Circ Res; 2008 Apr; 102(8):959-65. PubMed ID: 18323524 [TBL] [Abstract][Full Text] [Related]
22. Distinct roles of calmodulin and Ca Wang S; Li J; Liu Y; Zhang J; Zheng X; Sun X; Lei S; Kang Z; Chen X; Lei M; Hu H; Zeng X; Hao L Biochem Biophys Res Commun; 2020 Jun; 526(4):960-966. PubMed ID: 32303334 [TBL] [Abstract][Full Text] [Related]
23. Loss of β-adrenergic-stimulated phosphorylation of CaV1.2 channels on Ser1700 leads to heart failure. Yang L; Dai DF; Yuan C; Westenbroek RE; Yu H; West N; de la Iglesia HO; Catterall WA Proc Natl Acad Sci U S A; 2016 Dec; 113(49):E7976-E7985. PubMed ID: 27864509 [TBL] [Abstract][Full Text] [Related]
24. The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes. Pereira L; Métrich M; Fernández-Velasco M; Lucas A; Leroy J; Perrier R; Morel E; Fischmeister R; Richard S; Bénitah JP; Lezoualc'h F; Gómez AM J Physiol; 2007 Sep; 583(Pt 2):685-94. PubMed ID: 17599964 [TBL] [Abstract][Full Text] [Related]
25. Ca2+-dependent calcineurin/NFAT signaling in β-adrenergic-induced cardiac hypertrophy. Khalilimeybodi A; Daneshmehr A; Sharif Kashani B Gen Physiol Biophys; 2018 Jan; 37(1):41-56. PubMed ID: 29424351 [TBL] [Abstract][Full Text] [Related]
26. TRPC channels as effectors of cardiac hypertrophy. Eder P; Molkentin JD Circ Res; 2011 Jan; 108(2):265-72. PubMed ID: 21252153 [TBL] [Abstract][Full Text] [Related]
27. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128 [TBL] [Abstract][Full Text] [Related]
28. E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling. Tsai CY; Kuo WW; Shibu MA; Lin YM; Liu CN; Chen YH; Day CH; Shen CY; Viswanadha VP; Huang CY PLoS One; 2017; 12(9):e0184153. PubMed ID: 28863192 [TBL] [Abstract][Full Text] [Related]
29. Calmodulin mediates differential sensitivity of CaMKII and calcineurin to local Ca2+ in cardiac myocytes. Saucerman JJ; Bers DM Biophys J; 2008 Nov; 95(10):4597-612. PubMed ID: 18689454 [TBL] [Abstract][Full Text] [Related]
30. Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft. Dries E; Santiago DJ; Johnson DM; Gilbert G; Holemans P; Korte SM; Roderick HL; Sipido KR J Physiol; 2016 Oct; 594(20):5923-5939. PubMed ID: 27121757 [TBL] [Abstract][Full Text] [Related]
31. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927 [TBL] [Abstract][Full Text] [Related]
32. The other side of cardiac Ca(2+) signaling: transcriptional control. Domínguez-Rodríguez A; Ruiz-Hurtado G; Benitah JP; Gómez AM Front Physiol; 2012; 3():452. PubMed ID: 23226134 [TBL] [Abstract][Full Text] [Related]
33. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy. Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257 [TBL] [Abstract][Full Text] [Related]
34. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades. Dai H; Jia G; Liu X; Liu Z; Wang H Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447 [TBL] [Abstract][Full Text] [Related]
35. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27. Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704 [TBL] [Abstract][Full Text] [Related]